Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

Geron Corporation's Rytelo gains FDA approval for MDS treatment, with promising sales and positive analyst outlook. Click ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

Operator instructions] I would now like to turn the conference over to Aron Feingold, vice president of investor relations ...

Shares of Geron Co. (NASDAQ:GERN – Get Free Report) have been assigned an average recommendation of “Buy” from the eleven ...

H.C. Wainwright initiated coverage of Geron (NASDAQ:GERN) with a buy rating, citing the potential of its recently approved ...

H.C. Wainwright has recently initiated Geron Corp (GERN) stock to Buy rating, as announced on November 5, 2024, according to Finviz. Earlier, on October 16, 2024, Scotiabank had initiated the stock to ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced members of the management team are scheduled to partic ...

Analyst Faisal Khurshid from Leerink Partners reiterated a Buy rating on Geron (GERN – Research Report) and keeping the price target at ...

Geron (GERN) stock gains as the company reported strong Q3 earnings and secured a $375M funding deal with Royalty Pharma and ...

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Geron (GERN – Research Report), with a price target of ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...